CervoMed CRVO
NASDAQ CRVO
$1.77 +0.40 (+29.20%)
At close: Nov 11, 2026 · 4:00 PM EST

CervoMed (CRVO) Net Income Attributable to Noncontrolling Interests (2012 - 2013)

Updated

CervoMed (CRVO) recorded Income from Non-Controlling Interests of -$13,634 in Q3 2013, compared with $18,779 a year earlier.

Analysis

CervoMed (CRVO) Net Income Attributable to Noncontrolling Interests (2012 - 2013) Analysis & Trends

On a TTM basis, CervoMed's Income from Non-Controlling Interests came in at -$9,286 as of Sep 30, 2013.

  • The Q3 2013 figure is the lowest quarterly Income from Non-Controlling Interests since Q1 2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCI Net Income (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 2.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -1.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 10.00 Mn
10 CervoMed 20.73 Mn -57.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 -2.61 Mn
Sep 30, 2013 -13,634.00
Jun 30, 2013 -7,752.00
Mar 31, 2013 -6,679.00
Dec 31, 2012 -7.36 Mn
Sep 30, 2012 -1.44 Mn
Jun 30, 2012 84.00
Mar 31, 2012 -16,196.00
API Access

CervoMed Net Income Attributable to Noncontrolling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=CRVO&period=max&api_key=YOUR_API_KEY